Winnable

Open tenders / IT & software

Planned procurement · Notice 107075-2026

PME for Tissue and Cell Management System

King's College Hospital NHS Foundation Trust

Value
£375k
Stage
Early notice
Where
London
Lots
1
Suitable for SMEs
Yes, says the buyer
Contract
3 May 2027 – 2 May 2032

In plain English

King's College Hospital NHS Foundation Trust is running early market engagement, not an open tender, to find suppliers of a tissue and cell management system for its stem cell transplant and cellular therapy laboratory in London. The current contract period is shown as 3 May 2027 to 2 May 2032, with an estimated value of £375,000, and the Trust expects a formal procurement to follow.

Good fit for: Healthcare software suppliers with a laboratory tissue and cell tracking system, ideally one already used in UK hospitals.

The catch (with the notice's own words):
  • Must meet HTA licensing and FACT-JACIE standards enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards
  • Supplier must support system validation before go-live Supplier support for installation, operational and performance qualification (IQ/OQ/PQ) will be required before go-live
  • Must meet strict electronic record and data integrity standards meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems) and 21 CFR Part 11

Written with AI. Always bid from the official notice.

What the buyer says

King's College Hospital NHS Foundation Trust ("the Trust") is carrying out preliminary market engagement under the Procurement Act 2023 to understand the solutions available for a tissue and cell management system supporting its stem cell transplantation and cellular therapy laboratory services. The Trust currently uses a commercial off-the-shelf tissue and cell management system, in live use since 2023. The infrastructure on which it runs reaches end of support in January 2027, and the Trust is assessing its options for continuity of service from 2027. These include upgrading or migrating the existing solution and adopting an alternative solution. The purpose of this engagement is to establish which providers of this type of system exist in the market, and their level of interest, to help the Trust decide on the most appropriate route to market and timescales. The outcome will inform the Trust's requirements, options appraisal and business case, and the Trust anticipates that it will be followed by a formal procurement. The Trust is seeking solutions that provide end-to-end management and traceability of cellular therapy products, from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. The solution will need to support: • labelling and traceability in line with ICCBBA ISBT 128 standards; • a complete and secure audit trail; • quality management, including deviations and non-conformances; • inventory and storage location management; and • reporting. The solution will need to enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards. It should also meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems…

What happens next

This is an early notice: the buyer is planning a tender, and its documents come when the tender is published. Read the official notice for the details.

Procedure: not stated. Published 11 Nov 2026.

Similar open tenders

Want tenders like this, matched to your firm?

Winnable emails the few new tenders that fit you each weekday, with the catch spelled out. £29/month after a 14-day free trial (no card needed).

Start free trial